Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis

SIMPLE SUMMARY: The relation between HER2-low status in breast cancer and the hormone receptor-positive breast cancer recurrence score—oncotype recurrence score—is not very well studied. We conducted a study to look at the utility of the oncotype recurrence score in HER2-low and HER2-zero breast can...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Arya Mariam, Jiang, Changchuan, Perimbeti, Stuthi, Deng, Lei, Shapiro, Charles L., Gandhi, Shipra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486548/
https://www.ncbi.nlm.nih.gov/pubmed/37686540
http://dx.doi.org/10.3390/cancers15174264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486548/
https://www.ncbi.nlm.nih.gov/pubmed/37686540
http://dx.doi.org/10.3390/cancers15174264

Ejemplares similares